UniProt ID | PDIA4_HUMAN | |
---|---|---|
UniProt AC | P13667 | |
Protein Name | Protein disulfide-isomerase A4 | |
Gene Name | PDIA4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 645 | |
Subcellular Localization | Endoplasmic reticulum lumen . Melanosome . Identified by mass spectrometry in melanosome fractions from stage I to stage IV (PubMed:17081065). | |
Protein Description | ||
Protein Sequence | MRPRKAFLLLLLLGLVQLLAVAGAEGPDEDSSNRENAIEDEEEEEEEDDDEEEDDLEVKEENGVLVLNDANFDNFVADKDTVLLEFYAPWCGHCKQFAPEYEKIANILKDKDPPIPVAKIDATSASVLASRFDVSGYPTIKILKKGQAVDYEGSRTQEEIVAKVREVSQPDWTPPPEVTLVLTKENFDEVVNDADIILVEFYAPWCGHCKKLAPEYEKAAKELSKRSPPIPLAKVDATAETDLAKRFDVSGYPTLKIFRKGRPYDYNGPREKYGIVDYMIEQSGPPSKEILTLKQVQEFLKDGDDVIIIGVFKGESDPAYQQYQDAANNLREDYKFHHTFSTEIAKFLKVSQGQLVVMQPEKFQSKYEPRSHMMDVQGSTQDSAIKDFVLKYALPLVGHRKVSNDAKRYTRRPLVVVYYSVDFSFDYRAATQFWRSKVLEVAKDFPEYTFAIADEEDYAGEVKDLGLSESGEDVNAAILDESGKKFAMEPEEFDSDTLREFVTAFKKGKLKPVIKSQPVPKNNKGPVKVVVGKTFDSIVMDPKKDVLIEFYAPWCGHCKQLEPVYNSLAKKYKGQKGLVIAKMDATANDVPSDRYKVEGFPTIYFAPSGDKKNPVKFEGGDRDLEHLSKFIEEHATKLSRTKEEL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
101 | Phosphorylation | CKQFAPEYEKIANIL HHHHHHHHHHHHHHH | 22.82 | - | |
103 | Ubiquitination | QFAPEYEKIANILKD HHHHHHHHHHHHHCC | 46.33 | 21890473 | |
103 | Ubiquitination | QFAPEYEKIANILKD HHHHHHHHHHHHHCC | 46.33 | 21890473 | |
103 | Ubiquitination | QFAPEYEKIANILKD HHHHHHHHHHHHHCC | 46.33 | 21890473 | |
111 | 2-Hydroxyisobutyrylation | IANILKDKDPPIPVA HHHHHCCCCCCCCCE | 71.23 | - | |
119 | 2-Hydroxyisobutyrylation | DPPIPVAKIDATSAS CCCCCCEEEECCCHH | 41.16 | - | |
119 | Ubiquitination | DPPIPVAKIDATSAS CCCCCCEEEECCCHH | 41.16 | - | |
123 | O-linked_Glycosylation | PVAKIDATSASVLAS CCEEEECCCHHHHHH | 22.52 | OGP | |
124 | Phosphorylation | VAKIDATSASVLASR CEEEECCCHHHHHHC | 21.92 | 21712546 | |
126 | Phosphorylation | KIDATSASVLASRFD EEECCCHHHHHHCCC | 19.89 | 23403867 | |
130 | Phosphorylation | TSASVLASRFDVSGY CCHHHHHHCCCCCCC | 29.35 | 21712546 | |
135 | Phosphorylation | LASRFDVSGYPTIKI HHHCCCCCCCCEEEE | 34.16 | 23403867 | |
137 | Phosphorylation | SRFDVSGYPTIKILK HCCCCCCCCEEEEEE | 6.95 | 23403867 | |
141 | Ubiquitination | VSGYPTIKILKKGQA CCCCCEEEEEECCCC | 44.45 | 21890473 | |
141 | 2-Hydroxyisobutyrylation | VSGYPTIKILKKGQA CCCCCEEEEEECCCC | 44.45 | - | |
141 | Ubiquitination | VSGYPTIKILKKGQA CCCCCEEEEEECCCC | 44.45 | 21890473 | |
141 | Ubiquitination | VSGYPTIKILKKGQA CCCCCEEEEEECCCC | 44.45 | 21890473 | |
144 | Ubiquitination | YPTIKILKKGQAVDY CCEEEEEECCCCCCC | 59.33 | - | |
151 | Phosphorylation | KKGQAVDYEGSRTQE ECCCCCCCCCCCCHH | 18.65 | 28152594 | |
154 | Phosphorylation | QAVDYEGSRTQEEIV CCCCCCCCCCHHHHH | 21.88 | 28152594 | |
156 | Phosphorylation | VDYEGSRTQEEIVAK CCCCCCCCHHHHHHH | 41.87 | 23312004 | |
163 | Ubiquitination | TQEEIVAKVREVSQP CHHHHHHHHHHCCCC | 30.82 | - | |
168 | Phosphorylation | VAKVREVSQPDWTPP HHHHHHCCCCCCCCC | 31.10 | 21712546 | |
173 | Phosphorylation | EVSQPDWTPPPEVTL HCCCCCCCCCCCEEE | 33.04 | - | |
216 | Phosphorylation | CKKLAPEYEKAAKEL HHHHHHHHHHHHHHH | 22.98 | 28152594 | |
218 | Ubiquitination | KLAPEYEKAAKELSK HHHHHHHHHHHHHHH | 53.38 | - | |
227 | Phosphorylation | AKELSKRSPPIPLAK HHHHHHCCCCCCCCC | 38.47 | 23911959 | |
234 | 2-Hydroxyisobutyrylation | SPPIPLAKVDATAET CCCCCCCCCCCCCCC | 48.61 | - | |
234 | Ubiquitination | SPPIPLAKVDATAET CCCCCCCCCCCCCCC | 48.61 | - | |
238 | Phosphorylation | PLAKVDATAETDLAK CCCCCCCCCCCHHHH | 22.14 | - | |
241 | Phosphorylation | KVDATAETDLAKRFD CCCCCCCCHHHHHCC | 33.57 | - | |
245 | 2-Hydroxyisobutyrylation | TAETDLAKRFDVSGY CCCCHHHHHCCCCCC | 61.98 | - | |
245 | Succinylation | TAETDLAKRFDVSGY CCCCHHHHHCCCCCC | 61.98 | 23954790 | |
245 | Ubiquitination | TAETDLAKRFDVSGY CCCCHHHHHCCCCCC | 61.98 | - | |
250 | Phosphorylation | LAKRFDVSGYPTLKI HHHHCCCCCCCCEEE | 34.16 | 28152594 | |
252 | Phosphorylation | KRFDVSGYPTLKIFR HHCCCCCCCCEEEEE | 5.87 | 28152594 | |
254 | Phosphorylation | FDVSGYPTLKIFRKG CCCCCCCCEEEEECC | 32.00 | 28152594 | |
256 | Ubiquitination | VSGYPTLKIFRKGRP CCCCCCEEEEECCCC | 42.13 | 21890473 | |
256 | Acetylation | VSGYPTLKIFRKGRP CCCCCCEEEEECCCC | 42.13 | 88011 | |
256 | Ubiquitination | VSGYPTLKIFRKGRP CCCCCCEEEEECCCC | 42.13 | 21890473 | |
256 | Ubiquitination | VSGYPTLKIFRKGRP CCCCCCEEEEECCCC | 42.13 | 21890473 | |
264 | Phosphorylation | IFRKGRPYDYNGPRE EEECCCCCCCCCCHH | 29.69 | 28152594 | |
266 | Phosphorylation | RKGRPYDYNGPREKY ECCCCCCCCCCHHHC | 19.04 | 28152594 | |
270 | Methylation | PYDYNGPREKYGIVD CCCCCCCHHHCCHHH | 55.21 | 115486859 | |
272 | 2-Hydroxyisobutyrylation | DYNGPREKYGIVDYM CCCCCHHHCCHHHHH | 50.48 | - | |
272 | Acetylation | DYNGPREKYGIVDYM CCCCCHHHCCHHHHH | 50.48 | 25038526 | |
273 | Phosphorylation | YNGPREKYGIVDYMI CCCCHHHCCHHHHHH | 13.82 | 28348404 | |
278 | Phosphorylation | EKYGIVDYMIEQSGP HHCCHHHHHHHCCCC | 6.79 | - | |
279 | Sulfoxidation | KYGIVDYMIEQSGPP HCCHHHHHHHCCCCC | 2.05 | 30846556 | |
287 | Phosphorylation | IEQSGPPSKEILTLK HHCCCCCCHHEEEHH | 46.16 | - | |
294 | Ubiquitination | SKEILTLKQVQEFLK CHHEEEHHHHHHHHH | 43.09 | 21890473 | |
294 | 2-Hydroxyisobutyrylation | SKEILTLKQVQEFLK CHHEEEHHHHHHHHH | 43.09 | - | |
294 | Ubiquitination | SKEILTLKQVQEFLK CHHEEEHHHHHHHHH | 43.09 | 21890473 | |
294 | Ubiquitination | SKEILTLKQVQEFLK CHHEEEHHHHHHHHH | 43.09 | 21890473 | |
320 | Phosphorylation | KGESDPAYQQYQDAA CCCCCHHHHHHHHHH | 11.09 | 27642862 | |
323 | Phosphorylation | SDPAYQQYQDAANNL CCHHHHHHHHHHHHH | 7.88 | - | |
334 | Phosphorylation | ANNLREDYKFHHTFS HHHHHHHHHHCCCCH | 15.71 | 28152594 | |
335 | 2-Hydroxyisobutyrylation | NNLREDYKFHHTFST HHHHHHHHHCCCCHH | 51.01 | - | |
335 | Acetylation | NNLREDYKFHHTFST HHHHHHHHHCCCCHH | 51.01 | 27452117 | |
339 | Phosphorylation | EDYKFHHTFSTEIAK HHHHHCCCCHHHHHH | 15.65 | 28152594 | |
341 | Phosphorylation | YKFHHTFSTEIAKFL HHHCCCCHHHHHHHH | 26.70 | 28152594 | |
342 | Phosphorylation | KFHHTFSTEIAKFLK HHCCCCHHHHHHHHC | 27.50 | 28152594 | |
351 | Phosphorylation | IAKFLKVSQGQLVVM HHHHHCCCCCCEEEE | 27.31 | 23911959 | |
358 | Sulfoxidation | SQGQLVVMQPEKFQS CCCCEEEECCHHHHC | 4.25 | 21406390 | |
362 | 2-Hydroxyisobutyrylation | LVVMQPEKFQSKYEP EEEECCHHHHCCCCC | 56.22 | - | |
362 | Acetylation | LVVMQPEKFQSKYEP EEEECCHHHHCCCCC | 56.22 | 27452117 | |
365 | Phosphorylation | MQPEKFQSKYEPRSH ECCHHHHCCCCCCCC | 40.10 | 29449344 | |
366 | 2-Hydroxyisobutyrylation | QPEKFQSKYEPRSHM CCHHHHCCCCCCCCC | 42.73 | - | |
366 | Acetylation | QPEKFQSKYEPRSHM CCHHHHCCCCCCCCC | 42.73 | 19608861 | |
367 | Phosphorylation | PEKFQSKYEPRSHMM CHHHHCCCCCCCCCC | 36.09 | 22817900 | |
371 | Phosphorylation | QSKYEPRSHMMDVQG HCCCCCCCCCCCCCC | 26.84 | 28258704 | |
373 | Sulfoxidation | KYEPRSHMMDVQGST CCCCCCCCCCCCCCC | 2.30 | 21406390 | |
374 | Sulfoxidation | YEPRSHMMDVQGSTQ CCCCCCCCCCCCCCC | 3.70 | 30846556 | |
379 | Phosphorylation | HMMDVQGSTQDSAIK CCCCCCCCCCHHHHH | 13.05 | 28258704 | |
380 | Phosphorylation | MMDVQGSTQDSAIKD CCCCCCCCCHHHHHH | 43.13 | 20068231 | |
383 | Phosphorylation | VQGSTQDSAIKDFVL CCCCCCHHHHHHHHH | 23.29 | 20068231 | |
386 | Acetylation | STQDSAIKDFVLKYA CCCHHHHHHHHHHHH | 44.84 | 26822725 | |
391 | Ubiquitination | AIKDFVLKYALPLVG HHHHHHHHHHHHHCC | 24.15 | 21890473 | |
391 | Acetylation | AIKDFVLKYALPLVG HHHHHHHHHHHHHCC | 24.15 | 25038526 | |
391 | Ubiquitination | AIKDFVLKYALPLVG HHHHHHHHHHHHHCC | 24.15 | 21890473 | |
391 | Ubiquitination | AIKDFVLKYALPLVG HHHHHHHHHHHHHCC | 24.15 | 21890473 | |
392 | Phosphorylation | IKDFVLKYALPLVGH HHHHHHHHHHHHCCC | 14.81 | 24927040 | |
403 | Phosphorylation | LVGHRKVSNDAKRYT HCCCCCCCCCHHHHC | 31.84 | 24719451 | |
409 | Phosphorylation | VSNDAKRYTRRPLVV CCCCHHHHCCCCEEE | 12.14 | 24719451 | |
410 | Phosphorylation | SNDAKRYTRRPLVVV CCCHHHHCCCCEEEE | 25.00 | 24719451 | |
437 | 2-Hydroxyisobutyrylation | ATQFWRSKVLEVAKD HHHHHHHHHHHHHHH | 42.12 | - | |
448 | Phosphorylation | VAKDFPEYTFAIADE HHHHCCCCEEEEECC | 13.85 | - | |
449 | Phosphorylation | AKDFPEYTFAIADEE HHHCCCCEEEEECCC | 12.62 | - | |
458 | Phosphorylation | AIADEEDYAGEVKDL EEECCCCCCCCCCCC | 21.56 | - | |
468 | Phosphorylation | EVKDLGLSESGEDVN CCCCCCCCCCCCCCC | 28.11 | 25693802 | |
470 | Phosphorylation | KDLGLSESGEDVNAA CCCCCCCCCCCCCHH | 44.07 | 26657352 | |
482 | Phosphorylation | NAAILDESGKKFAME CHHEECCCCCEECCC | 56.43 | 25693802 | |
484 | Acetylation | AILDESGKKFAMEPE HEECCCCCEECCCHH | 54.73 | 69971 | |
484 | Ubiquitination | AILDESGKKFAMEPE HEECCCCCEECCCHH | 54.73 | - | |
485 | Acetylation | ILDESGKKFAMEPEE EECCCCCEECCCHHH | 41.71 | 27452117 | |
488 | Sulfoxidation | ESGKKFAMEPEEFDS CCCCEECCCHHHCCH | 11.26 | 30846556 | |
495 | Phosphorylation | MEPEEFDSDTLREFV CCHHHCCHHHHHHHH | 37.50 | - | |
503 | O-linked_Glycosylation | DTLREFVTAFKKGKL HHHHHHHHHHHCCCC | 31.53 | 55829001 | |
506 | 2-Hydroxyisobutyrylation | REFVTAFKKGKLKPV HHHHHHHHCCCCCCC | 59.14 | - | |
506 | Acetylation | REFVTAFKKGKLKPV HHHHHHHHCCCCCCC | 59.14 | 7479711 | |
509 | Acetylation | VTAFKKGKLKPVIKS HHHHHCCCCCCCCCC | 63.32 | 7350211 | |
516 | Phosphorylation | KLKPVIKSQPVPKNN CCCCCCCCCCCCCCC | 28.70 | - | |
528 | 2-Hydroxyisobutyrylation | KNNKGPVKVVVGKTF CCCCCCEEEEEECEE | 32.23 | - | |
528 | Succinylation | KNNKGPVKVVVGKTF CCCCCCEEEEEECEE | 32.23 | 27452117 | |
533 | 2-Hydroxyisobutyrylation | PVKVVVGKTFDSIVM CEEEEEECEECEEEC | 34.11 | - | |
533 | Acetylation | PVKVVVGKTFDSIVM CEEEEEECEECEEEC | 34.11 | 26822725 | |
540 | Sulfoxidation | KTFDSIVMDPKKDVL CEECEEECCCCCCEE | 7.52 | 21406390 | |
543 | 2-Hydroxyisobutyrylation | DSIVMDPKKDVLIEF CEEECCCCCCEEEEE | 58.29 | - | |
543 | Succinylation | DSIVMDPKKDVLIEF CEEECCCCCCEEEEE | 58.29 | 23954790 | |
551 | Phosphorylation | KDVLIEFYAPWCGHC CCEEEEEECCCCCCC | 10.04 | 24719451 | |
565 | Phosphorylation | CKQLEPVYNSLAKKY CHHHHHHHHHHHHHH | 15.11 | - | |
567 | Phosphorylation | QLEPVYNSLAKKYKG HHHHHHHHHHHHHCC | 16.41 | 24719451 | |
570 | Succinylation | PVYNSLAKKYKGQKG HHHHHHHHHHCCCCC | 63.03 | 23954790 | |
572 | Phosphorylation | YNSLAKKYKGQKGLV HHHHHHHHCCCCCEE | 21.46 | 20068231 | |
576 | 2-Hydroxyisobutyrylation | AKKYKGQKGLVIAKM HHHHCCCCCEEEEEE | 63.98 | - | |
576 | Ubiquitination | AKKYKGQKGLVIAKM HHHHCCCCCEEEEEE | 63.98 | - | |
583 | Sulfoxidation | KGLVIAKMDATANDV CCEEEEEEECCCCCC | 2.91 | 21406390 | |
586 | Phosphorylation | VIAKMDATANDVPSD EEEEEECCCCCCCCC | 23.02 | - | |
592 | Phosphorylation | ATANDVPSDRYKVEG CCCCCCCCCCCEECC | 34.27 | 21712546 | |
594 | Methylation | ANDVPSDRYKVEGFP CCCCCCCCCEECCCC | 37.19 | 115486867 | |
595 | Phosphorylation | NDVPSDRYKVEGFPT CCCCCCCCEECCCCE | 25.11 | 28152594 | |
596 | Acetylation | DVPSDRYKVEGFPTI CCCCCCCEECCCCEE | 34.40 | 26051181 | |
602 | Phosphorylation | YKVEGFPTIYFAPSG CEECCCCEEEECCCC | 26.50 | 28152594 | |
604 | Phosphorylation | VEGFPTIYFAPSGDK ECCCCEEEECCCCCC | 9.00 | - | |
608 | Phosphorylation | PTIYFAPSGDKKNPV CEEEECCCCCCCCCC | 57.08 | - | |
616 | Acetylation | GDKKNPVKFEGGDRD CCCCCCCCCCCCCCC | 38.67 | 27452117 | |
629 | 2-Hydroxyisobutyrylation | RDLEHLSKFIEEHAT CCHHHHHHHHHHHHH | 57.64 | - | |
629 | Acetylation | RDLEHLSKFIEEHAT CCHHHHHHHHHHHHH | 57.64 | 26051181 | |
637 | 2-Hydroxyisobutyrylation | FIEEHATKLSRTKEE HHHHHHHHHHHCHHC | 45.29 | - | |
637 | Acetylation | FIEEHATKLSRTKEE HHHHHHHHHHHCHHC | 45.29 | 27452117 | |
639 | Phosphorylation | EEHATKLSRTKEEL- HHHHHHHHHCHHCC- | 39.19 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PDIA4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PDIA4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PDIA4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ASNS_HUMAN | ASNS | physical | 22863883 | |
CAN2_HUMAN | CAPN2 | physical | 22863883 | |
MOES_HUMAN | MSN | physical | 22863883 | |
ULA1_HUMAN | NAE1 | physical | 22863883 | |
LIS1_HUMAN | PAFAH1B1 | physical | 22863883 | |
PA1B2_HUMAN | PAFAH1B2 | physical | 22863883 | |
IPP2_HUMAN | PPP1R2 | physical | 22863883 | |
PLPHP_HUMAN | PROSC | physical | 22863883 | |
GDS1_HUMAN | RAP1GDS1 | physical | 22863883 | |
TATD1_HUMAN | TATDN1 | physical | 22863883 | |
EFTU_HUMAN | TUFM | physical | 22863883 | |
1433E_HUMAN | YWHAE | physical | 22863883 | |
1433F_HUMAN | YWHAH | physical | 22863883 | |
PDIA1_HUMAN | P4HB | physical | 26344197 | |
EMC7_HUMAN | EMC7 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-366, AND MASS SPECTROMETRY. |